跳至主要内容
临床试验/IRCT201507226135N5
IRCT201507226135N5已完成未知

To evaluate the safety and efficacy of M3D Fractional - Made By Medaria in reducing facial aging: A single arm phase III clinical trial

Medaria Company0 个研究点目标入组 15 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30 years 至 60 years(—)
性别
All

入选标准

  • Aged between 30 to 60 years.
  • Mild to moderate (Glogaue Score)
  • Skin Type (II-IV)
  • Signed informed consent voluntarily and knowingly
  • Exclusion criteria
  • History of any implant in face area
  • History of any cosmetic surgery during last 3 years in face area
  • History of RF during last year
  • History of any Botulinum, laser, or intense pulsed light during last 6 month
  • History of Isotretinoin during last 6 month
  • Collagen vascular disease
  • Severe cardiac disease
  • Malignant tumor
  • Bleeding disorders, Coagulopathy, any drugs affect bleeding time
  • Any active, chronic and recurrent infection
  • Any history of anaphylaxis
  • Susceptibility to keloids
  • Any active or recurrent herpes
  • Any immune-compromised conditions
  • Skin atrophy
  • Active smoker ( last 2 years)
  • Pregnancy/ breast feeding
  • Vascular disease
  • Cardiac pace maker
  • Vertigo, labyrinthitis
  • Dyslipidemia

排除标准

  • 未提供

研究者

发起方
Medaria Company

相似试验